Aramco CEO: The energy transition strategy has not achieved success
Pharmaceutical companies in Egypt are increasingly demanding to raise the prices of their products based on the high cost of imported production inputs, which represent 90% of locally manufactured drug inputs, after the liberalization of the exchange rate earlier this month, which raises questions about the fair price for the consumer amid rising inflation to … Read more